v3.26.1
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current Assets    
Cash and cash equivalents $ 766,460 $ 836,417
Short-term investments 305,688 417,800
Restricted cash 5,100 5,100
Prepaid expenses 10,654 4,877
Accounts and other receivables, net (2025 - $5,452 from related party) 13,190 8,378
Total current assets 1,101,092 1,272,572
Property, plant and equipment, net 3,323 1,924
In-process research and development 16,900 16,900
Intangible assets, net 438 527
Goodwill 8,255 8,255
Long-lead material work in process 68,553 63,767
Investments 820,849 32,954
Other assets 29,783 15,613
Total Assets 2,049,193 1,412,512
Current Liabilities    
Accounts payable and accrued expenses 19,764 286,515
Accrued compensation 8,308 8,280
Other accrued liabilities 756 648
Deferred revenue 240 613
Total current liabilities 29,068 296,056
Noncurrent liabilities 5,955 2,570
Deferred revenue 513 335
Total Liabilities 35,536 298,961
Stockholders’ Equity    
Additional paid-in capital 2,885,691 1,901,678
Accumulated deficit (824,425) (732,871)
Total Stockholders’ Equity Excluding Noncontrolling Interests 2,061,309 1,168,841
Noncontrolling interests (47,652) (55,290)
Total Stockholders' Equity 2,013,657 1,113,551
Total Liabilities and Stockholders' Equity 2,049,193 1,412,512
Class A    
Stockholders’ Equity    
Common stock, value 41 32
Class B    
Stockholders’ Equity    
Common stock, value $ 2 $ 2